• Users Online: 98
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 10  |  Issue : 4  |  Page : 238-241

Online survey for symptoms following COVID-19 postvaccination in Karnataka: A cross-sectional study


1 Department of General Medicine, Jawaharlal Nehru Medical College, KAHER, Belgavi, Karnataka, India
2 Department of Hospital Administration, Jawaharlal Nehru Medical College, KAHER, Belgavi, Karnataka, India
3 Department of Public Health, Jawaharlal Nehru Medical College, KAHER, Belgavi, Karnataka, India
4 Department of Medical Under Graduate Student Researcher, Jawaharlal Nehru Medical College, KAHER, Belgavi, Karnataka, India

Correspondence Address:
Ass Prof. A B Kudachi
Department of Hospital Administration, Jawaharlal Nehru Medical College, KAHER, Belgavi, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ajim.ajim_97_21

Rights and Permissions

Background: While the protective efficacy of vaccine is frequently discussed, little is known about the real-world postvaccination experience outside of clinical trial conditions. The objective of the study was to assess the immediate response to the first and second dose of COVID-19 vaccine and to study the spectrum of postvaccination symptom profile for individuals' vaccines. Materials and Methods: A cross-sectional online survey was done using Google Forms. It was circulated via electronic media to the people who had taken COVID-19 vaccine from July 1 to July 30, 2021. Data were analyzed using SPSS version 20.00. Results: A total of 610 people responded to the online survey. Majority (29%) of respondents belonged to the 20–30 years' age group, followed by 30–40 years' age group (24%). The respondents were predominantly males (82%) and belonging to urban area (57%). Almost 57% of the people had taken Covishield, with the rest having received Covaxin. About 53% of the people had taken the first dose of vaccine. The respondents reported postvaccination symptoms as follows: fever (56%), muscle pain (47%), headache (45%), redness (35%), tiredness (33%), itching (30%), joint pain (30%), and swelling (27%). A total of 45% of participants experienced some health problems and 69% had taken medications after vaccination to relieve the symptoms. A statistically significant association was observed between first dose of COVID-19 vaccine and gender of the participants (P = 0.0024). A similar association was also observed between the dose of COVID-19 vaccine and presence of postvaccination symptoms, namely, fever (P = 0.0001), headache (P = 0.0001), muscle pain (P = 0.0010), tiredness (P = 0.029), breathlessness (P = 0.001), and joint pains (P = 0.012). Conclusion: Post-COVID vaccination symptoms are very common in the community irrespective of age and gender.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed269    
    Printed6    
    Emailed0    
    PDF Downloaded40    
    Comments [Add]    

Recommend this journal